Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages

Chien Min Lin, Hidetaka Arishima, Ken ichiro Kikuta, Hironobu Naiki, Ryuhei Kitai, Toshiaki Kodera, Ken Matsuda, Norichika Hashimoto, Makoto Isozaki, Kenzo Tsunetoshi, Hiroyuki Neishi, Yoshifumi Higashino, Ayumi Akazawa, Hiroshi Arai, Shinsuke Yamada

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cerebral amyloid angiopathy (CAA) is a degenerative disorder characterized by amyloid-β (Aβ) deposition in the brain microvessels. CAA is also known to contribute not only to cortical microbleeds but also lobar hemorrhages. This retrospective study examined CAA pathologically in patients who underwent direct surgeries for lobar hemorrhage. Thirty-three patients with lobar hemorrhage underwent open surgery with biopsy from 2007 to 2016 in our hospital. Cortical tissues over hematomas obtained surgically were pathologically examined using hematoxylin, eosin stain, and anti-Aβ antibody to diagnose CAA. We also investigated the advanced degree of CAA and clinical features of each patient with lobar hemorrhage. In the 33 patients, 4 yielded specimens that were insufficient to evaluate CAA pathologically. Twenty-four of the remaining 29 patients (82.8%) were pathologically diagnosed with CAA. The majority of CAA-positive patients had moderate or severe CAA based on a grading scale to estimate the advanced degree of CAA. About half of the CAA-positive patients had hypertension, and four took anticoagulant or antiplatelet agents. In five patients who were not pathologically diagnosed with CAA, one had severe liver function disorder, three had uncontrollable hypertension, and one had no obvious risk factor. Our pathological findings suggest that severe CAA with vasculopathic change markedly contributes to lobar hemorrhage. The coexistence of severe CAA and risk factors such as hypertension, anticoagulants or antiplatelets may readily induce lobar hemorrhage.

Original languageEnglish
Pages (from-to)567-577
Number of pages11
JournalJournal of Neurology
Volume265
Issue number3
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Cerebral Amyloid Angiopathy
Hemorrhage
Hypertension
Anticoagulants
Platelet Aggregation Inhibitors
Hematoxylin
Eosine Yellowish-(YS)
Microvessels

Keywords

  • Cerebral amyloid angiopathy
  • Lobar hemorrhages
  • Pathological examination

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages. / Lin, Chien Min; Arishima, Hidetaka; Kikuta, Ken ichiro; Naiki, Hironobu; Kitai, Ryuhei; Kodera, Toshiaki; Matsuda, Ken; Hashimoto, Norichika; Isozaki, Makoto; Tsunetoshi, Kenzo; Neishi, Hiroyuki; Higashino, Yoshifumi; Akazawa, Ayumi; Arai, Hiroshi; Yamada, Shinsuke.

In: Journal of Neurology, Vol. 265, No. 3, 01.03.2018, p. 567-577.

Research output: Contribution to journalArticle

Lin, CM, Arishima, H, Kikuta, KI, Naiki, H, Kitai, R, Kodera, T, Matsuda, K, Hashimoto, N, Isozaki, M, Tsunetoshi, K, Neishi, H, Higashino, Y, Akazawa, A, Arai, H & Yamada, S 2018, 'Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages', Journal of Neurology, vol. 265, no. 3, pp. 567-577. https://doi.org/10.1007/s00415-018-8740-z
Lin, Chien Min ; Arishima, Hidetaka ; Kikuta, Ken ichiro ; Naiki, Hironobu ; Kitai, Ryuhei ; Kodera, Toshiaki ; Matsuda, Ken ; Hashimoto, Norichika ; Isozaki, Makoto ; Tsunetoshi, Kenzo ; Neishi, Hiroyuki ; Higashino, Yoshifumi ; Akazawa, Ayumi ; Arai, Hiroshi ; Yamada, Shinsuke. / Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages. In: Journal of Neurology. 2018 ; Vol. 265, No. 3. pp. 567-577.
@article{12df8541ccca42ed975d9dd161fcaf91,
title = "Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages",
abstract = "Cerebral amyloid angiopathy (CAA) is a degenerative disorder characterized by amyloid-β (Aβ) deposition in the brain microvessels. CAA is also known to contribute not only to cortical microbleeds but also lobar hemorrhages. This retrospective study examined CAA pathologically in patients who underwent direct surgeries for lobar hemorrhage. Thirty-three patients with lobar hemorrhage underwent open surgery with biopsy from 2007 to 2016 in our hospital. Cortical tissues over hematomas obtained surgically were pathologically examined using hematoxylin, eosin stain, and anti-Aβ antibody to diagnose CAA. We also investigated the advanced degree of CAA and clinical features of each patient with lobar hemorrhage. In the 33 patients, 4 yielded specimens that were insufficient to evaluate CAA pathologically. Twenty-four of the remaining 29 patients (82.8{\%}) were pathologically diagnosed with CAA. The majority of CAA-positive patients had moderate or severe CAA based on a grading scale to estimate the advanced degree of CAA. About half of the CAA-positive patients had hypertension, and four took anticoagulant or antiplatelet agents. In five patients who were not pathologically diagnosed with CAA, one had severe liver function disorder, three had uncontrollable hypertension, and one had no obvious risk factor. Our pathological findings suggest that severe CAA with vasculopathic change markedly contributes to lobar hemorrhage. The coexistence of severe CAA and risk factors such as hypertension, anticoagulants or antiplatelets may readily induce lobar hemorrhage.",
keywords = "Cerebral amyloid angiopathy, Lobar hemorrhages, Pathological examination",
author = "Lin, {Chien Min} and Hidetaka Arishima and Kikuta, {Ken ichiro} and Hironobu Naiki and Ryuhei Kitai and Toshiaki Kodera and Ken Matsuda and Norichika Hashimoto and Makoto Isozaki and Kenzo Tsunetoshi and Hiroyuki Neishi and Yoshifumi Higashino and Ayumi Akazawa and Hiroshi Arai and Shinsuke Yamada",
year = "2018",
month = "3",
day = "1",
doi = "10.1007/s00415-018-8740-z",
language = "English",
volume = "265",
pages = "567--577",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "D. Steinkopff-Verlag",
number = "3",

}

TY - JOUR

T1 - Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages

AU - Lin, Chien Min

AU - Arishima, Hidetaka

AU - Kikuta, Ken ichiro

AU - Naiki, Hironobu

AU - Kitai, Ryuhei

AU - Kodera, Toshiaki

AU - Matsuda, Ken

AU - Hashimoto, Norichika

AU - Isozaki, Makoto

AU - Tsunetoshi, Kenzo

AU - Neishi, Hiroyuki

AU - Higashino, Yoshifumi

AU - Akazawa, Ayumi

AU - Arai, Hiroshi

AU - Yamada, Shinsuke

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Cerebral amyloid angiopathy (CAA) is a degenerative disorder characterized by amyloid-β (Aβ) deposition in the brain microvessels. CAA is also known to contribute not only to cortical microbleeds but also lobar hemorrhages. This retrospective study examined CAA pathologically in patients who underwent direct surgeries for lobar hemorrhage. Thirty-three patients with lobar hemorrhage underwent open surgery with biopsy from 2007 to 2016 in our hospital. Cortical tissues over hematomas obtained surgically were pathologically examined using hematoxylin, eosin stain, and anti-Aβ antibody to diagnose CAA. We also investigated the advanced degree of CAA and clinical features of each patient with lobar hemorrhage. In the 33 patients, 4 yielded specimens that were insufficient to evaluate CAA pathologically. Twenty-four of the remaining 29 patients (82.8%) were pathologically diagnosed with CAA. The majority of CAA-positive patients had moderate or severe CAA based on a grading scale to estimate the advanced degree of CAA. About half of the CAA-positive patients had hypertension, and four took anticoagulant or antiplatelet agents. In five patients who were not pathologically diagnosed with CAA, one had severe liver function disorder, three had uncontrollable hypertension, and one had no obvious risk factor. Our pathological findings suggest that severe CAA with vasculopathic change markedly contributes to lobar hemorrhage. The coexistence of severe CAA and risk factors such as hypertension, anticoagulants or antiplatelets may readily induce lobar hemorrhage.

AB - Cerebral amyloid angiopathy (CAA) is a degenerative disorder characterized by amyloid-β (Aβ) deposition in the brain microvessels. CAA is also known to contribute not only to cortical microbleeds but also lobar hemorrhages. This retrospective study examined CAA pathologically in patients who underwent direct surgeries for lobar hemorrhage. Thirty-three patients with lobar hemorrhage underwent open surgery with biopsy from 2007 to 2016 in our hospital. Cortical tissues over hematomas obtained surgically were pathologically examined using hematoxylin, eosin stain, and anti-Aβ antibody to diagnose CAA. We also investigated the advanced degree of CAA and clinical features of each patient with lobar hemorrhage. In the 33 patients, 4 yielded specimens that were insufficient to evaluate CAA pathologically. Twenty-four of the remaining 29 patients (82.8%) were pathologically diagnosed with CAA. The majority of CAA-positive patients had moderate or severe CAA based on a grading scale to estimate the advanced degree of CAA. About half of the CAA-positive patients had hypertension, and four took anticoagulant or antiplatelet agents. In five patients who were not pathologically diagnosed with CAA, one had severe liver function disorder, three had uncontrollable hypertension, and one had no obvious risk factor. Our pathological findings suggest that severe CAA with vasculopathic change markedly contributes to lobar hemorrhage. The coexistence of severe CAA and risk factors such as hypertension, anticoagulants or antiplatelets may readily induce lobar hemorrhage.

KW - Cerebral amyloid angiopathy

KW - Lobar hemorrhages

KW - Pathological examination

UR - http://www.scopus.com/inward/record.url?scp=85040764390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040764390&partnerID=8YFLogxK

U2 - 10.1007/s00415-018-8740-z

DO - 10.1007/s00415-018-8740-z

M3 - Article

VL - 265

SP - 567

EP - 577

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 3

ER -